FDA Clears ViewRay MR-Radiotherapy Device for Premarket

Matthew Skoufalos | | Radiology Business | Magnetic Resonance Imaging
The FDA has cleared an MRI-guided radiation therapy system developed by the Cleveland, OH-based ViewRay, Inc. for premarket notification. Last year, the administration approved the ViewRay treatment planning and delivery software for premarketing as well. Now the company says its combined solution soon will be commercially available for the treatment of simultaneous MR and radiotherapy for cancer patients. ViewRay installed research versions of its initial systems in various locations throughout the United States this year.

Matthew Skoufalos

Related Content

Radiologists are more accurate, confident when they know the full story
Rads are more accurate when they have access to patients' self-reported symptoms
Imaging startup Ezra launches ‘world’s most advanced longevity scan’ at $5,995 a pop
Whole-body MRI startup Ezra expands service in partnership with Princeton Radiology
Siemens Healthineers signs imaging value partnership worth over $60M
Outdated manuals pose MRI safety risks for patients with medical implants

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Design by Adaptive Theme
Trimed Popup
Trimed Popup